Skip to content

Clinical trials

Phase 2 Inflammatory Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Phase: Phase 2 Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20033
20041
20055
20061
20074
20082
20091
20103
20111
20122
20132
20152
20163
20176
20182
20192
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting10
Terminated9
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center11
City of Hope Medical Center5
National Cancer Institute (NCI)3
Dana-Farber Cancer Institute2
GlaxoSmithKline2
H. Lee Moffitt Cancer Center and Research Institute2
UNC Lineberger Comprehensive Cancer Center2
Academic and Community Cancer Research United1
Auxilio Mutuo Cancer Center1
BerGenBio ASA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms50
Breast Neoplasms39
Triple Negative Breast Neoplasms8
Carcinoma, Ductal, Breast6
Breast Neoplasms, Male5
Carcinoma, Lobular5
Edema2
Erythema2
Breast Carcinoma In Situ1
Disease1

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.